Research map: Long‐Acting Growth Hormone Versus Daily Growth Hormone for Growth Hormone Deficiency Patients: A Network Meta‐Analysis of Clinical Trials

Back to the article

Papers in this map

  1. RoB 2: a revised tool for assessing risk of bias in randomised trials · Jonathan A C Sterne · 2019 · 33351 citations · Cited by this paper
  2. Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era · 2026 · Related
  3. CINeMA: An approach for assessing confidence in the results of a network meta-analysis · Adriani Nikolakopoulou · 2020 · 1919 citations · Cited by this paper
  4. An Evaluation of Longitudinal Thyroid Hormone Levels Over the Years Before and After Patients Started on Levothyroxine · 2026 · Related
  5. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study · Cheri Deal · 2022 · 113 citations · Cited by this paper
  6. The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes ( DIREM ): A Single Blind Randomised Controlled Trial · 2026 · Related
  7. Weekly Lonapegsomatropin in Treatment–Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial · PAUL S. THORNTON · 2021 · 88 citations · Cited by this paper
  8. Frequency of Insulin Resistance in Overweight Patients With Metabolic‐Associated Fatty Liver Disease ( MAFLD ) at a Tertiary Healthcare Centre in Bangladesh · 2026 · Related
  9. Identifying Potentially Modifiable Factors Associated with Treatment Non-Adherence in Paediatric Growth Hormone Deficiency: A Systematic Review · Selina Graham · 2018 · 86 citations · Cited by this paper
  10. Self‐Efficacy, Self‐Care, Glycaemic Control, and Quality of Life Among Adults With Type 2 Diabetes: A Scoping Review · 2026 · Related
  11. Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial · Bradley Scott Miller · 2022 · 75 citations · Cited by this paper
  12. Efficacy of Metformin in Prevention of Glucocorticoid‐Induced Hyperglycemia in Patients Without Diabetes: A Meta‐Analysis · 2026 · Related
  13. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial · Lars S Savendahl · 2020 · 67 citations · Cited by this paper
  14. A Clinically Aligned Two‐Stage Machine Learning Framework for Predicting Hungry Bone Syndrome After Parathyroidectomy · 2026 · Related
  15. Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis · Chiara Mameli · 2023 · 58 citations · Cited by this paper
  16. Comparative Effectiveness of CagriSegma , Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials · 2026 · Related
  17. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3 · Lars S Savendahl · 2021 · 54 citations · Cited by this paper
  18. Predicting Diabetic Foot Ulcer Outcomes: Machine Learning‐Based Refinement of IWGDF ‐Approved Classifications for Outpatient Services · 2026 · Related
  19. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study · Reiko Horikawa · 2022 · 44 citations · Cited by this paper
  20. Reassessing Agreement Between Point of Care and Laboratory Triglyceride Measurements in High Risk Pregnancy · 2026 · Related
  21. Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology · Jung Hee Kim · 2020 · 38 citations · Cited by this paper
  22. Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement · Aristides K Maniatis · 2024 · 37 citations · Cited by this paper
  23. Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results · Aristides K Maniatis · 2022 · 31 citations · Cited by this paper
  24. Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH · Bradley Scott Miller · 2023 · 28 citations · Cited by this paper
  25. Experience of switching from a daily to a less frequent administration of injection treatments · Jane Loftus · 2022 · 22 citations · Cited by this paper
  26. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial · Aristides K Maniatis · 2022 · 21 citations · Cited by this paper
  27. Effective growth hormone replacement with once‐weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial · Jun Mori · 2024 · 17 citations · Cited by this paper
  28. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency · Hanze Du · 2022 · 15 citations · Cited by this paper
  29. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency · Yan Liang · 2022 · 14 citations · Cited by this paper
  30. Somapacitan is Effective and Well Tolerated in Chinese Children with Growth Hormone Deficiency: a Randomised Controlled Phase 3 Study · Junfen Fu · 2025 · 12 citations · Cited by this paper
  31. Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4 · Bradley Scott Miller · 2025 · 12 citations · Cited by this paper
  32. A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency · Yan Liang · 2024 · 11 citations · Cited by this paper
  33. Gene Expression Signatures Predict First-Year Response to Somapacitan Treatment in Children With Growth Hormone Deficiency · Terence Garner · 2023 · 9 citations · Cited by this paper
  34. Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency · Norbert Albers · 2025 · 9 citations · Cited by this paper
  35. Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results · Aristides K Maniatis · 2025 · 9 citations · Cited by this paper
  36. IGF-1 Assessment During Weekly Somatrogon Treatment in Pediatric Patients With GH Deficiency · Satyaprakash Nayak · 2025 · 7 citations · Cited by this paper
  37. Update on the use of long-acting growth hormone in children · Margaret Cristina da Silva Boguszewski · 2024 · 5 citations · Cited by this paper
  38. Should the initial dose of long-acting growth hormone therapy somatrogon for pediatric growth hormone deficiency be standard for each child? · Eren Er · 2025 · 1 citation · Cited by this paper
  39. Adherence to growth hormone treatment in the transition age: A prospective observational multicenter study · Chiara Guzzetti · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)